CD8A and neoplasm: Initially, CD8+ T-cell gene transduction was undertaken using retroviral vectors to clone tumour-specific TCRα and β chains, generating CD8+ T cells that specifically recognised tumour-associated antigens in an MHC-I-dependent manner.